 Fatty Liver
"Fatty Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Descriptor ID |
D005234
|
| MeSH Number(s) |
C06.552.241
|
| Concept/Terms |
Steatohepatitis- Steatohepatitis
- Steatohepatitides
- Steatosis of Liver
- Visceral Steatosis
- Steatoses, Visceral
- Steatosis, Visceral
- Visceral Steatoses
- Liver Steatosis
- Liver Steatoses
- Steatoses, Liver
- Steatosis, Liver
|
Below are MeSH descriptors whose meaning is more general than "Fatty Liver".
Below are MeSH descriptors whose meaning is more specific than "Fatty Liver".
This graph shows the total number of publications written about "Fatty Liver" by people in this website by year, and whether "Fatty Liver" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2005 | 3 | 1 | 4 | | 2006 | 2 | 0 | 2 | | 2007 | 5 | 1 | 6 | | 2008 | 4 | 1 | 5 | | 2009 | 8 | 4 | 12 | | 2010 | 2 | 3 | 5 | | 2011 | 10 | 4 | 14 | | 2012 | 12 | 1 | 13 | | 2013 | 14 | 4 | 18 | | 2014 | 8 | 1 | 9 | | 2015 | 5 | 0 | 5 | | 2016 | 2 | 2 | 4 | | 2017 | 4 | 0 | 4 | | 2018 | 4 | 1 | 5 | | 2020 | 3 | 1 | 4 | | 2021 | 4 | 0 | 4 | | 2022 | 2 | 0 | 2 | | 2023 | 2 | 0 | 2 | | 2024 | 3 | 4 | 7 | | 2025 | 6 | 0 | 6 | | 2026 | 9 | 1 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Fatty Liver" by people in Profiles.
-
Hoffman EA, Phoebe AM, Trujillo MN, Zhang WC, Jennings EQ, Farrera DO, Orlicky DJ, Rutt LN, McCullough RL, Huacachino AA, Marcinkiewicz MM, Snyder NW, Bruner KR, Payan KB, Martinez DJF, Stern JH, Galligan JJ. Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice. Physiol Rep. 2026 Sep; 14(17):e71106.
-
Lake JE, Kitch DW, Kantor A, Mayo R, Belaunzaran-Zamudio P, Fichtenbaum CJ, Brown TT, Corey KE, Sattler F, Erlandson KM. Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study. HIV Med. 2026 Oct; 27(10):1710-1714.
-
Chan AP, Czernuszewicz TJ, Lai RW, Jarrett KE, Lau A, Warshan A, Cheng AS, Steel ME, Schmidt HM, Larios J, Little I, Rubert GE, Brearley-Sholto MC, Mamouei Z, Pesner JK, Hamad CD, Francis KP, Bernthal NM, Redente EF, Magyar CE, French SW, Williams KJ, Tarling EJ, de Aguiar Vallim TQ. Intestinal lipase inhibition uncouples diet-induced obesity from MASH by remodeling the hepatic lipidome in mice. J Lipid Res. 2026 Aug; 67(8):101112.
-
Violet PC, Greene T, Teng S, Wang Y, Leonard SW, Head B, Wright EC, Shamburek R, Traber MG, Levine M, Ebenuwa I. Postprandial Vitamin E Plasma Enrichment and Second Meal Effect in Women with and without Metabolic Dysfunction-Associated Steatotic Liver Disease. J Nutr. 2026 Sep; 156(9):101717.
-
Zemski Berry K, Garfield A, Macias E, Zarini S, Bowen S, Cree MG, Snell-Bergeon JK, Bodkin S, Bergman BC. Weight loss reduces intermuscular adipose tissue and liver fat compared to exercise: implications for muscle quality and metabolic health. J Clin Endocrinol Metab. 2026 Jun 17; 111(7):1994-2007.
-
Zelber-Sagi S, Ivancovsky-Wajcman D, Kugelmas C, Weinstein AA, Wong VW, Castera L, Moore JB, Mouzaki M, Hallsworth K, Paik JM, Schwimmer JB, Gerber LH, Younossi ZM. Lifespan approaches for the prevention and management of steatotic liver disease. Nat Rev Gastroenterol Hepatol. 2026 Jul; 23(7):526-548.
-
Pednekar AS, Kilpattu Ramaniharan A, Greer JS, Debnath P, Trout AT, Dillman JR, Manhard MK. Impact of hepatic steatosis and MOLLI acquisition parameters on liver T1 estimates. Abdom Radiol (NY). 2026 Oct; 51(10):4920-4930.
-
Boster JM, Cree MG, Kelsey MM, Nadeau KJ, Chaidez A, Pan Z, Sundaram SS. Relative Skeletal Muscle Mass Is Associated With Hepatic Steatosis in Adolescents With Overweight and Obesity. Pediatr Obes. 2026 Apr; 21(4):e70108.
-
Salmon K, Cohen CC, Lange L, Dabelea D, Perng W. Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. Nutrients. 2026 Mar 28; 18(7).
-
Kalhori A, Cole RM, Zarich S, Li N, Kolipaka A, Ni A, Sparagna GC, Belury MA. Plasma linoleic acid is related to lower hepatic steatosis index and higher linoleate-rich cardiolipin in adults with MAFLD. Am J Physiol Gastrointest Liver Physiol. 2026 04 01; 330(4):G478-G486.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|